About L & C Bio
L & C Bio is a company based in Seongnam-si (South Korea) founded in 2011.. The company has 135 employees as of December 31, 2024. L & C Bio operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Seongnam-si, South Korea
- Employees 135 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name L&C Bio Co., Ltd.
-
Annual Revenue
$48.88 M (USD)9.35as on Dec 31, 2024
-
Net Profit
$95.64 M (USD)191.69as on Dec 31, 2024
-
EBITDA
$5.75 M (USD)-33.26as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
135
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of L & C Bio
L & C Bio is a publicly listed company on the KRX with ticker symbol 290650 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of L & C Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by L & C Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - L C Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
L & C Bio Comparisons
Competitors of L & C Bio
L & C Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on L & C Bio
Frequently Asked Questions about L & C Bio
When was L & C Bio founded?
L & C Bio was founded in 2011.
Where is L & C Bio located?
L & C Bio is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
How many employees does L & C Bio have?
As of Dec 31, 2024, the latest employee count at L & C Bio is 135.
What is the annual revenue of L & C Bio?
Annual revenue of L & C Bio is $48.88M as on Dec 31, 2024.
What does L & C Bio do?
L C Bio was founded in 2011 and is based in Seongnam-si, South Korea. Allograft and xenograft solutions are developed across tissue engineering, medical devices, and cosmeceuticals. Manufacturing facilities are certified under ISO 9001 and GMP standards. Biomaterials for tissue repair, collagen-based supplements, implantable biomaterial bones, deep wound coverings, and bioabsorbable wound materials are produced. Operations focus on biomedical innovations for implantation and repair applications.
Who are the top competitors of L & C Bio?
L & C Bio's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Is L & C Bio publicly traded?
Yes, L & C Bio is publicly traded on KRX under the ticker symbol 290650.
What is L & C Bio's ticker symbol?
The ticker symbol of L & C Bio is 290650 on KRX.